Literature DB >> 15649982

Restriction of placental growth results in greater hypotensive response to alpha-adrenergic blockade in fetal sheep during late gestation.

Li Danielson1, I Caroline McMillen, Jodie L Dyer, Janna L Morrison.   

Abstract

Placental insufficiency resulting in restriction of fetal substrate supply and fetal hypoxaemia is a major cause of restricted fetal growth and increased neonatal morbidity. Fetal adaptations to placental restriction (PR) include increases in circulating catecholamines and cortisol and decreased fetal body growth, with relative sparing of brain growth. The mechanisms underlying the redistribution of fetal cardiac output in PR fetuses are not known and the aim of this study was to determine whether maintenance of fetal blood pressure (BP) in the PR fetus is dependent on alpha-adrenergic stimulation. PR was induced by removing the majority of uterine caruncles in the ewe before conception. Sterile vascular surgery was performed on seven PR and six control fetuses at 113-120 days' gestation (term = 150 +/- 3 days). Fetuses with a mean arterial PO2 < 17 mmHg between 123 and 127 days' gestation were defined as hypoxic. There was a greater fall (P < 0.05) in fetal BP during phentolamine infusion (i.v: 5 mg bolus, 0.2 mg kg(-1) min(-1) for 2 h) in the hypoxic PR group (-15 +/- 2 mmHg) compared with normoxic controls (-5 +/- 1 mmHg). The fall in fetal BP during phentolamine infusion was directly related to the level of fetal PO2. Fetal BP and HR responses to phenylephrine (i.v.: 40 microg kg(-1)) were not different between PR and control fetuses. The maintenance of BP in the chronically hypoxic fetus is therefore dependent on alpha-adrenergic activation, and this fetal adaptation to a suboptimal intrauterine environment pre-dates the development of significant growth restriction. While this adaptation may play a critical role in the redistribution of fetal cardiac output to ensure the sparing of brain growth, it may have adverse consequences for peripheral vascular function in the neonatal period and in adult life.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15649982      PMCID: PMC1665578          DOI: 10.1113/jphysiol.2004.080523

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  39 in total

1.  Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. The Vermont Oxford Network.

Authors:  I M Bernstein; J D Horbar; G J Badger; A Ohlsson; A Golan
Journal:  Am J Obstet Gynecol       Date:  2000-01       Impact factor: 8.661

2.  Adaptation of cardiovascular responses to repetitive umbilical cord occlusion in the late gestation ovine fetus.

Authors:  L R Green; Y Kawagoe; J Homan; S E White; B S Richardson
Journal:  J Physiol       Date:  2001-09-15       Impact factor: 5.182

3.  Fetal growth restriction: adaptations and consequences.

Authors:  I C McMillen; M B Adams; J T Ross; C L Coulter; G Simonetta; J A Owens; J S Robinson; L J Edwards
Journal:  Reproduction       Date:  2001-08       Impact factor: 3.906

4.  Fetal behavioural state changes following maternal fluoxetine infusion in sheep.

Authors:  J L Morrison; C Chien; N Gruber; D Rurak; W Riggs
Journal:  Brain Res Dev Brain Res       Date:  2001-11-26

5.  Cardiovascular responses to hypoxemia and acidemia in fetal lambs.

Authors:  H E Cohn; E J Sacks; M A Heymann; A M Rudolph
Journal:  Am J Obstet Gynecol       Date:  1974-11-15       Impact factor: 8.661

6.  The autonomic control of heart rate and insulin resistance in young adults.

Authors:  D E Flanagan; J C Vaile; G W Petley; V M Moore; I F Godsland; R A Cockington; J S Robinson; D I Phillips
Journal:  J Clin Endocrinol Metab       Date:  1999-04       Impact factor: 5.958

7.  Effects of prevailing hypoxaemia, acidaemia or hypoglycaemia upon the cardiovascular, endocrine and metabolic responses to acute hypoxaemia in the ovine fetus.

Authors:  D S Gardner; A J W Fletcher; M R Bloomfield; A L Fowden; D A Giussani
Journal:  J Physiol       Date:  2002-04-01       Impact factor: 5.182

8.  Sympathetic control of the cardiovascular response to acute hypoxemia in the chick embryo.

Authors:  A L M Mulder; A Miedema; J G R De Mey; D A Giussani; C E Blanco
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2002-04       Impact factor: 3.619

9.  Foetal respiratory movements, electrocortical and cardiovascular responses to hypoxaemia and hypercapnia in sheep.

Authors:  K Boddy; G S Dawes; R Fisher; S Pinter; J S Robinson
Journal:  J Physiol       Date:  1974-12       Impact factor: 5.182

10.  Blood redistribution in the fetal brain during chronic hypoxia.

Authors:  M Dubiel; G O Gunnarsson; S Gudmundsson
Journal:  Ultrasound Obstet Gynecol       Date:  2002-08       Impact factor: 7.299

View more
  33 in total

1.  Intrauterine growth restriction and differential patterns of hepatic growth and expression of IGF1, PCK2, and HSDL1 mRNA in the sheep fetus in late gestation.

Authors:  Sheridan Gentili; Janna L Morrison; I Caroline McMillen
Journal:  Biol Reprod       Date:  2009-02-04       Impact factor: 4.285

2.  Intrauterine growth-restricted sheep fetuses exhibit smaller hindlimb muscle fibers and lower proportions of insulin-sensitive Type I fibers near term.

Authors:  Dustin T Yates; Caitlin N Cadaret; Kristin A Beede; Hannah E Riley; Antoni R Macko; Miranda J Anderson; Leticia E Camacho; Sean W Limesand
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-04-06       Impact factor: 3.619

3.  IGF-2R-Gαq signaling and cardiac hypertrophy in the low-birth-weight lamb.

Authors:  Kimberley C W Wang; Darran N Tosh; Song Zhang; I Caroline McMillen; Jaime A Duffield; Doug A Brooks; Janna L Morrison
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-01-28       Impact factor: 3.619

4.  Modifying Maternal Sleep Position in Late Pregnancy Through Positional Therapy: A Feasibility Study.

Authors:  Jane Warland; Jillian Dorrian; Allan J Kember; Craig Phillips; Ali Borazjani; Janna L Morrison; Louise M O'Brien
Journal:  J Clin Sleep Med       Date:  2018-08-15       Impact factor: 4.062

5.  Increased adrenergic signaling is responsible for decreased glucose-stimulated insulin secretion in the chronically hyperinsulinemic ovine fetus.

Authors:  Sasha E Andrews; Laura D Brown; Stephanie R Thorn; Sean W Limesand; Melissa Davis; William W Hay; Paul J Rozance
Journal:  Endocrinology       Date:  2015-01       Impact factor: 4.736

6.  Maternal undernutrition in late gestation increases IGF2 signalling molecules and collagen deposition in the right ventricle of the fetal sheep heart.

Authors:  Jack R T Darby; I Caroline McMillen; Janna L Morrison
Journal:  J Physiol       Date:  2018-05-20       Impact factor: 5.182

7.  Skeletal muscle amino acid uptake is lower and alanine production is greater in late gestation intrauterine growth-restricted fetal sheep hindlimb.

Authors:  Eileen I Chang; Stephanie R Wesolowski; Elizabeth A Gilje; Peter R Baker; Julie A Reisz; Angelo D'Alessandro; William W Hay; Paul J Rozance; Laura D Brown
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-09-04       Impact factor: 3.619

8.  Fetal growth restriction and the programming of heart growth and cardiac insulin-like growth factor 2 expression in the lamb.

Authors:  Kimberley C W Wang; Lei Zhang; I Caroline McMillen; Kimberley J Botting; Jaime A Duffield; Song Zhang; Catherine M Suter; Doug A Brooks; Janna L Morrison
Journal:  J Physiol       Date:  2011-08-01       Impact factor: 5.182

9.  Activation of IGF-2R stimulates cardiomyocyte hypertrophy in the late gestation sheep fetus.

Authors:  Kimberley C W Wang; Doug A Brooks; Kent L Thornburg; Janna L Morrison
Journal:  J Physiol       Date:  2012-08-28       Impact factor: 5.182

10.  Chronic exposure to elevated norepinephrine suppresses insulin secretion in fetal sheep with placental insufficiency and intrauterine growth restriction.

Authors:  Rafael A Leos; Miranda J Anderson; Xiaochuan Chen; Juliana Pugmire; K Arbor Anderson; Sean W Limesand
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-01-19       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.